Prognostic significance of dissecting the nerve plexus around the common hepatic artery in pancreatic cancer

Langenbecks Arch Surg. 2021 May;406(3):679-689. doi: 10.1007/s00423-020-02025-4. Epub 2020 Nov 7.

Abstract

Purpose: This study aims to investigate the positivity rate of the nerve plexus (NPL) around the common hepatic artery (CHA), as well as the impact of dissecting the NPL-CHA, during surgical resection of pancreatic cancer.

Methods: Clinicopathological factors, including hematoxylin and eosin (H&E) staining and immunohistochemistry, were compared between the resectable pancreatic cancer (RPC) and borderline resectable PC (BRPC) groups. Moreover, the relationship between the NPL-CHA status and overall survival (OS) was investigated.

Results: In this study, 136 eligible patients were divided into the RPC (72) and BRPC (64) groups. In the RPC group, all patients were negative for H&E staining and microinvasion, whereas 13 (20%) and five patients (8%) were positive for H&E staining and microinvasion, respectively, in the BRPC group. The median OS times in the NPL-CHA-positive and -negative groups were 29.8 and 60.2 months, respectively (p = 0.088). The multivariate analysis of OS indicated an elevated initial carbohydrate antigen 19-9, lymph node (LN) metastasis, and lack of adjuvant chemotherapy (AC), which independently predicted poor outcomes. In the BRPC subgroup, contact with the CHA on preoperative computed tomography (CT) was a high-risk factor for NPL-CHA positivity.

Conclusion: NPL-CHA positivity was only present in the BRPC group. In the absence of CT evidence of CHA contact, NPL-CHA dissection may not have survival benefits.

Keywords: Common hepatic artery; Nerve plexus; Pancreatectomy; Pancreatic cancer; Resectability status.

MeSH terms

  • Hepatic Artery* / diagnostic imaging
  • Humans
  • Neoadjuvant Therapy
  • Pancreatectomy
  • Pancreatic Neoplasms* / surgery
  • Prognosis
  • Survival Rate